छोड़कर सामग्री पर जाएँ
Buy Zydus Wellness; target of Rs 1654: Sharekhan

Buy Zydus Wellness; target of Rs 1654: Sharekhan

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.

Read More

​ Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023. Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.  Moneycontrol Latest News Read More  

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.

Buy Zydus Wellness; target of Rs 1654: Sharekhan

Buy Zydus Wellness; target of Rs 1654: Sharekhan

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.

Read More

​ Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023. Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.  Moneycontrol Latest News Read More  

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.

Yatharth Hospital sees tepid listing: Should you buy, sell or hold?

Yatharth Hospital sees tepid listing: Should you buy, sell or hold?

The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.

Read More

​ The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses. The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.  Moneycontrol Latest News Read More  

The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.

Yatharth Hospital sees tepid listing: Should you buy, sell or hold?

Yatharth Hospital sees tepid listing: Should you buy, sell or hold?

The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.

Read More

​ The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses. The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.  Moneycontrol Latest News Read More  

The Rs 687-crore public issue had seen a healthy response from investors, subscribing 36.16 times during July 26-28. This led analysts and investors to believe that there would be another strong listing on bourses.

KIOCL share price falls 4% as company stops pellet production at Mangalore plant

KIOCL share price falls 4% as company stops pellet production at Mangalore plant

The share touched a 52-week high of Rs 245.95 and a 52-week low of Rs 165.20 on 01 August, 2023 and 29 March, 2023, respectively.

Read More

​ The share touched a 52-week high of Rs 245.95 and a 52-week low of Rs 165.20 on 01 August, 2023 and 29 March, 2023, respectively. The share touched a 52-week high of Rs 245.95 and a 52-week low of Rs 165.20 on 01 August, 2023 and 29 March, 2023, respectively.  Moneycontrol Latest News Read More  

The share touched a 52-week high of Rs 245.95 and a 52-week low of Rs 165.20 on 01 August, 2023 and 29 March, 2023, respectively.

Zen Technologies Q1 profit jumps multi-fold to Rs 47 crore

Zen Technologies Q1 profit jumps multi-fold to Rs 47 crore

Zen technologies had posted profit after tax (PAT) of Rs 7.46 crore in the same period a year ago, the company said in a regulatory filing.

Read More

​ Zen technologies had posted profit after tax (PAT) of Rs 7.46 crore in the same period a year ago, the company said in a regulatory filing. Zen technologies had posted profit after tax (PAT) of Rs 7.46 crore in the same period a year ago, the company said in a regulatory filing.  Moneycontrol Latest News Read More  

Zen technologies had posted profit after tax (PAT) of Rs 7.46 crore in the same period a year ago, the company said in a regulatory filing.

Elon Musk says he may need surgery, will get MRI on back and neck

Elon Musk says he may need surgery, will get MRI on back and neck

The world’s richest person said he will know this week whether surgery will be required, ahead of his proposed cage fight with Meta Platforms Inc. co-founder Mark Zuckerberg. He didn’t disclose any other details.

Read More

​ The world’s richest person said he will know this week whether surgery will be required, ahead of his proposed cage fight with Meta Platforms Inc. co-founder Mark Zuckerberg. He didn’t disclose any other details. The world’s richest person said he will know this week whether surgery will be required, ahead of his proposed cage fight with Meta Platforms Inc. co-founder Mark Zuckerberg. He didn’t disclose any other details.  Moneycontrol Latest News Read More  

The world’s richest person said he will know this week whether surgery will be required, ahead of his proposed cage fight with Meta Platforms Inc. co-founder Mark Zuckerberg. He didn’t disclose any other details.

Brokerages verdict on SBI Q1, Yatharth Hospitals listing  more | Market Minutes

Brokerages verdict on SBI Q1, Yatharth Hospitals listing more | Market Minutes

In this episode of Market Minutes, Shailaja Mohapatra talks about State Bank of India#39;s Q1 numbers, Yatharth Hospital listing expectations and highlights from RIL annual report. Catch Shilpa Rout of Prabhudas Lilladher in Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, keys data points and developing trends.rn rnDisclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.​

Read More

​ In this episode of Market Minutes, Shailaja Mohapatra talks about State Bank of India#39;s Q1 numbers, Yatharth Hospital listing expectations and highlights from RIL annual report. Catch Shilpa Rout of Prabhudas Lilladher in Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, keys data points and developing trends.rn rnDisclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.​ In this episode of Market Minutes, Shailaja Mohapatra talks about State Bank of India#39;s Q1 numbers, Yatharth Hospital listing expectations and highlights from RIL annual report. Catch Shilpa Rout of Prabhudas Lilladher in Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, keys data points and developing trends.rn rnDisclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.​  Moneycontrol Latest News Read More  

In this episode of Market Minutes, Shailaja Mohapatra talks about State Bank of India#39;s Q1 numbers, Yatharth Hospital listing expectations and highlights from RIL annual report. Catch Shilpa Rout of Prabhudas Lilladher in Voice of the Day segment. Market Minutes is a morning podcast that puts the spotlight on hot stocks, keys data points and developing trends.rn rnDisclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.​

Delhi services bill in Rajya Sabha today; Congress, AAP issue whip to MPs

Delhi services bill in Rajya Sabha today; Congress, AAP issue whip to MPs

The Government of National Capital Territory of Delhi (Amendment) Bill, 2023, has already been passed by Lok Sabha.

Read More

​ The Government of National Capital Territory of Delhi (Amendment) Bill, 2023, has already been passed by Lok Sabha. The Government of National Capital Territory of Delhi (Amendment) Bill, 2023, has already been passed by Lok Sabha.  Moneycontrol Latest News Read More  

The Government of National Capital Territory of Delhi (Amendment) Bill, 2023, has already been passed by Lok Sabha.

Vijay Shekhar Sharma to purchase 10.3% stake in Paytm from Antfin

Vijay Shekhar Sharma to purchase 10.3% stake in Paytm from Antfin

An overseas entity owned by Sharma will acquire 10.3 percent stake in Paytm from Antfin through an off-market transfer. On closing of this transaction, Sharma’s shareholding in Paytm will increase to 19.42 percent, whereas Antfin’s shareholding will reduce to 13.5 percent

Read More

​ An overseas entity owned by Sharma will acquire 10.3 percent stake in Paytm from Antfin through an off-market transfer. On closing of this transaction, Sharma’s shareholding in Paytm will increase to 19.42 percent, whereas Antfin’s shareholding will reduce to 13.5 percent An overseas entity owned by Sharma will acquire 10.3 percent stake in Paytm from Antfin through an off-market transfer. On closing of this transaction, Sharma’s shareholding in Paytm will increase to 19.42 percent, whereas Antfin’s shareholding will reduce to 13.5 percent  Moneycontrol Latest News Read More  

An overseas entity owned by Sharma will acquire 10.3 percent stake in Paytm from Antfin through an off-market transfer. On closing of this transaction, Sharma’s shareholding in Paytm will increase to 19.42 percent, whereas Antfin’s shareholding will reduce to 13.5 percent

hi_INहिन्दी